Objective: The prevalence of hypertension increases with advancing age in women. Blood pressure control is more difficult to achieve in older women, and despite well-controlled blood pressure, the cardiovascular mortality remains high. However, the underlying mechanisms are not understood.
D uring early and middle adulthood, men have a greater prevalence of hypertension (HTN) compared with women, but the prevalence and severity of HTN increase distinctly in women after menopause. [1] [2] [3] Indeed, the prevalence of HTN increases two-fold after menopause, independent of other traditional risk factors. 4, 5 Furthermore, after six decades of their lives, the prevalence of HTN-related cardiovascular complications is greater in older women compared with age-matched men, and these are the leading causes of death in women. 6, 7 Despite remarkable advances in pharmacotherapy, blood pressure (BP) control remains difficult to achieve, particularly in older women. The Framingham Heart Study revealed a sex difference in BP control rates, reporting an age-associated gradual decrease in BP control rates was more distinctive in women than in men. [8] [9] [10] [11] More importantly, it is noteworthy to mention that the clinical focus is overwhelmingly on BP control of hypertensive individuals. Although many epidemiological reports have shown the BP control with antihypertensive medications profoundly reduces the risk of cardiovascular disease in the HTN populations, several prospective observational studies revealed that the cardiovascular mortality rate remains high in HTN women, despite adequate BP control. [12] [13] [14] These counterintuitive clinical outcomes suggest that factors associated with the prevention of cardiovascular events in this population may be vastly complex and beyond BP control. However, little information is available from studies in humans on the physiological mechanisms involved.
The heart and vasculature are the main components of the human cardiovascular system, and interplay between cardiac and arterial factors determines the efficiency of the circulatory system. 15 The arterial afterload provides the main resistance to the left ventricle (LV) to generate the flow to the circulatory system and influences the magnitude of energy transmitted from the heart to peripheral circulation. Under conditions of chronically increased afterload, the LV is exposed to constant mechanical stress, leading to a left ventricular hypertrophy. Previous findings indicated a close association between left ventricular hypertrophy and cardiovascular outcomes in not only the general population but also hypertensive patients, [16] [17] [18] and there was a positive relationship between left ventricular mass and the severity of HTN. 19, 20 Left ventricular mass predicts future risk of cardiovascular events in both men and women, but a larger relative risk associated with left ventricular hypertrophy was found in women than in men. 19, 21 Clinical trials have shown that regression of left ventricular mass with antihypertensive drug treatment leads to a decrease in cardiovascular events. 22, 23 In addition, arterial load is closely associated with properties of large conduit arteries and the LV as a pump. Arterial load, composed of resistive and pulsatile components, is an important determinant of myocardial oxygen consumption and a key stimulus for myocardial hypertrophy. 24, 25 It has been demonstrated that the age-related stiffening of large arteries is more pronounced in women compared with their male counterparts. [26] [27] [28] The stiffer large arteries likely contributed to the greater prevalence of hypertension and its associated cardiovascular complications in older women. [26] [27] [28] To our knowledge, however, control of BP by antihypertensive drugs and its impact on unfavorable LV remodeling in older women remains grossly understudied, and comparative contributions of arterial load to LV in hypertensive older women is unknown.
Therefore, the purposes of this cross-sectional study was to compare the left ventricular remodeling and arterial properties in hypertensive older women with uncontrolled and controlled HTN, and also in older normotensive women. We hypothesized that current BP control by antihypertensive agents would not normalize cardiac morphology and arterial afterload in older women with hypertension.
METHODS

Participants
We studied 19 uncontrolled hypertensive women, 19 controlled hypertensive women, and 31 normotensive older women. Uncontrolled HTN is defined as ambulatory awake systolic pressure !140 mm Hg and/or diastolic pressure !90 mm Hg under stable antihypertensive medication regimens, and controlled HTN is systolic pressure lower than 140 mm Hg and/or diastolic pressure lower than 90 mm Hg on drug treatment. Volunteers with ambulatory awake systolic pressure !160 mm Hg and/or !100 mm Hg were excluded for safety reasons. We recruited participants who were between 60 and 85 years old, free of overt cardiovascular and other clinical diseases, diabetes mellitus (fasting glucose !126 mg/ dL or 2-hour oral glucose tolerance test; glucose level !200 mg/dL) and chronic kidney disease (serum creatinine >1.5 mg/dL), assessed by medical history, physical examination, resting ECG, urinalysis, and blood chemistries. All participants were postmenopausal, defined as the absence of menses for at least 2 years, and all were not on hormone therapy for at least 6 months before study participation.
After screening, hypertensive women were weaned progressively from their drugs (washout period) to eliminate the confounding influence of various antihypertensive medications, which was followed by a 3-week run-in period. During the run-in period, all participants were required to maintain a healthy lifestyle, according to the Eight Report of the Joint National Committee standard guidelines. 29 Twenty-four-hour ambulatory BP measurements (ABPM) (Oscar 2; SunTech Medical Instruments) were performed at the screening visit (before drug washout) and immediately after the end of the run-in period to assure the effect of antihypertensive agents were eliminated before data collection. We believe that 3-week run-in with no drug treatment would not dramatically change arterial properties and left ventricular morphology, because cardiovascular remodeling requires at least 4 months to occur. 30 The study was approved by the Institutional Review Board of the University of Texas Southwestern Medical Center and Texas Health Presbyterian Hospital Dallas, and conformed to the ethical standards of the Declaration of Helsinki. Before obtaining written informed consent, the purpose, nature, and risk of the study procedures were explained to the participants, and questions were addressed.
Cardiac magnetic resonance imaging
To evaluate the geometric cardiac remodelling, we used magnetic resonance imaging (MRI) which is the recommended method for clinical trials investigating left ventricular mass regression. 31 Cardiac MRI examinations were performed using a 1.5-T clinical MRI scanner (Gyroscan Intera, Philips). Short-axis slices of the heart images were obtained in 6 mm thickness with 4 mm gap. Measurements included left ventricular mass, end-diastolic (LVEDV) and end-systolic volumes (LVESV), and mass-to-volume ratio (LVR) by an experienced investigator who was blinded to participant characteristics. Obtained images were analyzed using the semiautomatic software tool of QMass V.7.2 (Medis Medical Imaging Systems, the Netherlands). Left ventricular wall thickness (LVWT) was measured on short-axis images at the midventricular level (papillary muscle level) in the anterior, inferior, lateral, and septal region. Cardiac MRI measurements were normalized by body surface area (BSA) and expressed as left ventricular mass index (LVMI), LVEDV index (LVEDVI), LVESV index (LVESVI), and LVWT index (LVWTI). All measurements were assessed at end diastole, which was identified as the frame with the largest left ventricular volume. The typical error of the withinindividual variability in the manual planning of cardiac MRI was 1.6% for LVMI and 1.3% for LVEDVI, and the between-individual typical error was 4.6% for LVMI and 4.1% for LVEDVI in our laboratory. We used carotid-to-femoral pulse wave velocity (central PWV) and carotid-to-radial PWV (peripheral PWV), the gold standard measurement of arterial stiffness, as indexes of central and peripheral arterial stiffness using the SphygmoCor MM3 system (AtCor Medical). Central PWV was determined by recording pressure pulse waves at the right carotid and femoral arteries using a high-fidelity micromanometer (Millar Instruments, Houston, TX) and calculating the distance between the recording sites divided by the time delay between the carotid and femoral pulse waves. Peripheral PWV was determined from the right carotid and radial waveforms. The distance was measured along the body surface using a nonstretchable tape. The straight distance from the carotid recording site to the suprasternal notch was subtracted from the suprasternal notch to the femoral recording site in the calculation of central PWV. The distance between the suprasternal notch and the carotid site added to suprasternal notch to the radial site in the calculation of peripheral PWV. At least three measurements were repeated, and the average of the three highest-quality recordings were used for analysis.
Wave reflection and LV afterload
Arterial wave reflection was assessed using the SphygmoCor system. Radial artery pressure waveforms were recorded by applanation tonometry with a high-fidelity micromanometer. A generalized transfer function, which has been validated both intra-arterially and noninvasively, was used to generate the aortic pressure waveform. The aortic pressure waveform provided the measurements of aortic BPs, central aortic pulse pressure (CPP), augmented pressure (AP; the difference between the first and second systolic shoulders of the aortic systolic BP), augmentation index (AIx), and AIx adjusted for a heart rate of 75 beats/min (AIx @ 75). Left ventricular wasted pressure energy (LVEw) 33, 34 is a component of extra myocardial oxygen requirement that is a result of early systolic wave reflection. LVEw was estimated as (1.333 Â [AP Â Dt r ] Â p/4), with 1.333 as the conversion factor for mm Hg/s to dynes Ã s/cm, and Dt r is the systolic duration of the reflected wave. At least three measurements were repeated, and the average of the three highest-quality recordings, established as an in-device operation quality index of >90%, were used for analysis.
Cardiac output and arterial afterload
Brachial cuff BP was measured by electrosphygmomanometry (model 4240; suntech Medical Instruments) with a microphone placed over the right brachial artery to detect Korotkoff sounds. Heart rate was recorded from lead II of the electrocardiogram. At least 20 minutes after instrumentation, cardiac output was measured by of the modified acetylene rebreathing method. 35, 36 Cardiac output and supine BPs were measured in 5-minute interval, at least three times, and the average value was recorded. All these variables were normalized by BSA. Total peripheral resistance (TPR) was determined as 80 Â mean BP divided by cardiac output. Effective arterial elastance (Ea) was defined as brachial SBP Â 0.9 divided by stroke volume. Total arterial compliance (TAC) was calculated as stroke volume divided by pulse pressure.
Arterial images
Image of the right common carotid artery was collected using an ultrasound/Doppler system (iE33, Philips) equipped with a high-resolution transducer (11 MHz) positioned at 2 cm proximal to the carotid bifurcation with simultaneous ECG recordings. Diameters were measured using image-analysis software (QLAB, Philips). Systolic and diastolic areas were averaged over four continuous beats. The carotid pressure waveforms were obtained with a tonometry transducer, and the signal was calibrated by the brachial diastolic and mean arterial pressure measured by arm cuff. Carotid arterial compliance, a measure of arterial buffering capacity, 37 was calculated as:
2 where D1 and D0 are the maximal and minimal carotid diameter, and P1 and P0 are the highest and lowest aortic pressures. Carotid arterial distensibility, a measure of arterial elastic properties, 38 was calculated as:
Study procedures
All measurements were performed in the morning !2 hours after light meal, in a quiet and environmentally controlled laboratory, with an ambient temperature of %258C (day 1). Participants abstained from alcohol, caffeine, medication use, and strenuous physical activity for at least 24 hours before data collection. At least 20 minutes after supine resting, cardiac output measurements were performed followed by arterial stiffness measurements. Central (carotid) and peripheral (brachial) BP were obtained using tonometry and arm cuff at the brachial artery, and central and peripheral PWV were assessed. Ultrasonography on the common carotid artery was performed for the assessment of carotid artery compliance. Cardiac MRI (for the assessment of cardiac morphology) was performed at the University of Texas Southwestern Medical Center at Dallas on a separate day (day 2). The MRI testing occurred at a similar time of the day as day 1 to eliminate possible diurnal variations.
While all participants (19 uncontrolled, 19 controlled, and 31 normotensives) successfully completed the other assessments during the procedure, not all but most of the participants (16 uncontrolled HTN, 15 controlled HTN, and 29 normotensive) completed cardiac MRI measurement.
Statistical analysis
Values are expressed as means AE SEM. Statistical analysis was performed using SPSS Statistics (Version 23, Chicago, IL), and statistical significance was set at P < 0.05. To examine differences among three groups, one-way analysis of variance (ANOVA) was used. The sample size calculation for a one-way ANOVA has been made based on the preliminary data obtained from our laboratory. We assumed that the minimum difference of left ventricular mass index to be detected was 5 g/m 2 , and that the estimated standard deviation YOO ET AL (SD) was 4.8 g/m 2 . We would need n ¼ 19 per group to detect the difference among the groups with power ¼ 0.80 and alpha ¼ 0.05. To examine the interaction between groups (uncontrolled vs controlled vs normotensive) and ABPM (screening vs run-in), a two-way (2 Â 2) mixed-factorial ANOVA, with repeated measures was used. Post hoc multiple comparisons were adjusted using the Bonferroni correction. To examine relationships of interest, Pearson productmoment correlation coefficients were used. Table 1 . Age, height, and weight were not different among the groups. Also, there were no group differences in body mass index and BSA. The percentage of antilipidemic and antihypothyroidic medication use was similar among the groups. Table 2 contains the percentage of BP medication use in uncontrolled and controlled HTN women, which shows similar results between the groups. Four participantes in the uncontrolled HTN group and two in the controlled HTN group were excluded during the washout and/or run-in period.
RESULTS
Participant characteristics are presented in
Ambulatory blood pressure
The ABPM data are presented in Table 3 . At the screening visit, ambulatory awake systolic and diastolic BP were similar between controlled HTN and normotensive women, but greater in uncontrolled HTN women compared with both groups (P ¼ 0.001). After the washout and 3-week run-in period, both ambulatory awake systolic and diastolic BP were elevated in controlled HTN women (P < 0.05), but remained the same in uncontrolled HTN women (P ¼ 0.5). Post run-in ABPM results were greater in the uncontrolled and controlled HTN groups compared with the normotensive group. Asleep ABPM results were similar to those of awake measurements.
Cardiac MRI measurements
The uncontrolled and controlled HTN groups showed greater LVMI compared with the normotensive group (Fig. 1A) . There was no difference in LVMI between the uncontrolled and controlled groups. Similarly, LVWTI was greater in uncontrolled and controlled HTN women compared with normotensive women (Fig. 1B) . LVEDVI and LVESVI were not different among three groups (Table 4) . LVR was higher in uncontrolled and controlled HTN women than in normotensive women.
Arterial stiffness, central BP, and wave reflection
Central PWV was greater in the uncontrolled and controlled HTN groups compared with the normotensive group, whereas there was no difference between the HTN groups (Table 5 ). There was no difference between uncontrolled and controlled HTN in carotid compliance and distensibility ( Table 5 ). The uncontrolled HTN group showed significantly lower carotid compliance and distensibility compared with the normotensive group (post hoc; P 0.01), whereas it was not significantly different compared to the controlled HTN group. There was no difference in carotid systolic and diastolic diameters among groups (Table 5) .
Central pulse pressure was greater in the HTN groups compared with the normotensive group. AP was the greatest in the uncontrolled HTN group and the lowest in the normotensive group (ANOVA, P ¼ 0.003; Table 5 ). AIx and AIx @ 75 were greater in the uncontrolled HTN group compared with the controlled HTN and normotensive groups (P 0.05; Table 5 ).
Cardiac and arterial afterload
The LVEw was greater in uncontrolled HTN compared with controlled HTN and normotensive women ( Fig. 2A) . LVEw was not different between controlled HTN and normotensive women. There was a significant positive correlation between LVEw and LVMI in uncontrolled and controlled HTN women (r ¼ 0.65, P ¼ 0.02; and r ¼ 0.58, P ¼ 0.03, respectively), but not in normotensive women (r ¼ À0.01, P ¼ 0.9). Total peripheral resistance was the greatest in uncontrolled HTN women and lowest in normotensive group (Fig. 2B) . There was no difference in TAC between uncontrolled and controlled HTN groups, and TAC was significantly lower in the uncontrolled group compared with normotensive group (Fig. 2C) . Ea index showed similar results as those of TAC (Fig. 2D) .
Hemodynamics parameters
Hemodynamic parameters are presented in Table 6 . Systolic and diastolic BP were greater in HTN groups compared with the normotensive group. Heart rate, Qc index, and SV index were not different among groups.
DISCUSSION
This is the first study to examine the differences in cardiac remodeling and arterial afterload in uncontrolled and controlled hypertensive older women. Our novel data showed that current BP control with antihypertensive drugs was not associated with favorable cardiac geometric remodeling and vascular de-stiffening in hypertensive older women. Left ventricular enlargement and vascular stiffness in this population seem to be independent of BP control status in our findings.
Cardiac geometric remodeling in hypertensive older women
Although meta-analysis studies indicated that stable antihypertensive drug treatment is associated with left ventricular hypertrophy regression, [39] [40] [41] hypertensive older women exhibited a greater LVMI and LVWTI compared with normotensive women in the current investigation regardless of current BP control status. It is possible that the discrepancy is mainly due to different study populations (eg, mixed sexes and wide age range of participants in meta-analysis vs only older women in our study). Previous cross-sectional studies demonstrated a clear sex-related difference in the left ventricular enlargement, [42] [43] [44] and older women appear to respond more sensitively to HTN and obesity than similarly aged men, as those factors are related to detrimental left ventricular changes. 45, 46 Despite antihypertensive treatment, left ventricular enlargement is more persistent in postmenopausal women, 47, 48 as our data consistently indicated, and it may partially explain the greater risk for cardiovascular events in an older hypertensive population even with well-controlled BP.
The meta-analysis studies suggest that angiotensinconverting enzyme inhibitors, angiotensin II receptor antagonists, and calcium channel blockers are superior to beta blockers and diuretics in the regression of left ventricular YOO ET AL hypertrophy. [39] [40] [41] The observed left ventricular enlargement in the current study, independent of BP control, partially can be explained by the fact that about 60% of the participants were treated with beta blockers and diuretics. Also, there might be other factors, mainly sex hormone deficiency related, modulating the left ventricular geometric remodeling, exclusively in older hypertensive women, which warrant further investigations.
Arterial afterload and compliance in hypertensive older women
Another important finding is arterial afterload and carotid artery compliance were not different between the HTN groups. No group differences were observed between uncontrolled and controlled HTN women in arterial afterload, described by TPR and TAC. 49 In addition, Ea, the lumped index of effective resistive and pulsatile afterload, 50, 51 was not different between women suffering from uncontrolled and controlled HTN. Central arterial properties, carotid artery compliance, and distensibility were comparable with arterial afterload components. However, it is noteworthy that controlled HTN women showed no significant difference in aforementioned parameters compared with normotensive women, either. Recently, it was suggested that hypertensive individuals, who had long-term controlled BP, appeared to have delayed progression of arterial stiffness with age compared with those who persistently had uncontrolled BP. 52 Women with controlled HTN showed modestly lower, but not statistically significant, arterial afterload in the current study, and further investigations are necessary to clarify the association between arterial afterload factors and BP control rate in hypertensive older women.
LV wasted pressure energy in hypertensive older women
We examined for the first time the LVEw in hypertensive older women and its association with left ventricular enlargement. Prolonged exposure to elevated left ventricular afterload has been indicated as the main contributor of left ventricular hypertrophy development in HTN. 53, 54 LVEw was significantly lower in controlled HTN compared with uncontrolled HTN. Left ventricular afterload consists of steady resistive (arterial afterload) and pulsatile components, and the pulsatile component is dependent on central arterial properties and peripheral wave reflections. 55 Previous studies found that pulsatile components of left ventricular afterload, characterized by AP and wave reflection, is associated with left ventricular hypertrophy, and the impact of wave reflection on left ventricular afterload is determined by the interaction between amplitude of the AP and duration of ejection. 56, 57 LVEw was introduced as the parameter resulting from both AP amplitude and duration of wave reflection. 58 In our data, increased LVEw was correlated with LVMI in both uncontrolled and controlled HTN, and it is consistent with the previous finding that LVEw contributes to left ventricular remodeling in the hypertensive population. 58 Based on the correlation between LVEw and LVMI in hypertensive women, the relation between two factors might be causative, but further prospective cohort study is required to establish the definite causal relationship.
Study limitations
Our study has several limitations. First of all, because of the nature of the cross-sectional design with a relatively small sample size, it is not appropriate to develop further interpretation regarding the causal relationship between HTN and cardiac-arterial alterations. However, in light of the evidence we found, it is possible to set a hypothesis for future largescale longitudinal studies investigating the association between LV enlargement and HTN control. Secondly, we did not document the time since the diagnosis of hypertension and/or onset of antihypertensive treatment. The time exposed to pressure overload by high BP is a critical determinant in cardiac adaptation, and the duration of antihypertensive treatment is closely associated with regression of HTN-induced cardiac and vascular alterations. However, the primary focus of the current study was to evaluate the characteristics of cardiac-vascular components in hypertensive older women with uncontrolled and controlled BP. Future studies need to examine the time-dependent impact of various hypertensive drugs on cardiac-vascular alterations. Third, we did not collect information regarding the age of menopause transition and past history/duration of hormone therapy. There is growing awareness that menopause and hormone therapy play an important role in cardiovascular physiology in older women. However, all participants did not use hormonal supplements for at least 6 months before participating in the study. Lastly, our participants were older hypertensive women, free of major cardiovascular, pulmonary, neurological, and/or renal diseases, but a portion of them were on a stable drug regimen, apart from an antihypertensive, for controlling hypothyroidism or elevated blood lipids. Although this may have influenced our results, the percentage of medication use was similar among groups; therefore, this factor should not influence the observed group differences. It is common for older women to be on antilipidemic and antihypothyroidism medications, which enhances the generalizability of our findings to the general older female population.
CONCLUSIONS A key concept emerging from current investigation is HTN in older women with an antihypertensive drug treatment exhibited left ventricular enlargement compared with normotensive counterparts independent of current BP control status. Adequate BP control was not correspondingly associated with favorable characteristics of cardiac and arterial function. Our observations possibly set up hypotheses explaining why the risk of cardiovascular mortality remains high in older hypertensive women regardless of BP control status. Large sample size prospective studies are warrant for better understanding of the relationships between left ventricular enlargement, arterial load, and BP control. It is an important question for the rational choice of antihypertensive treatment to achieve ''beyond BP control,'' specifically targeted to improve residual cardiovascular risk factors. There may be opportunity for strategies to further reduce cardiovascular morbidity, which could correlate with changes in LV remodeling.
